Clinical Trials Browser

Phase 2 × Recruiting × Small Cell Lung Cancer Limited Stage × Clear all

NCT06483282 2025-04-15

A Study of Adebrelimab Combined With Apatinib Mesylate and Chemotherapy for Neoadjuvant Therapy and Biomarker Analysis in Limited-stage Small Cell Lung Cancer

Phase 2 Recruiting

Small Cell Lung Cancer Limited Stage